Qilu Pharmaceutical
China - JinanPharmaceutical
Focus: Qilu Pharmaceutical is a 5,000+ employee Chinese generics and API manufacturer headquartered in Jinan, founded in 1958, with a diversified portfolio spanning oncology, infectious diseases, immunology, neurology, and hematology.
Profile data last refreshed 4d ago · AI intelligence enriched 3w ago
Employees
5000+
Open Jobs
0
About Qilu Pharmaceutical
AI assessmentNot HiringNo open roles listed right now. Follow Qilu Pharmaceutical to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Pre-Launch
CDK4/6 inhibitor in pre-launch phase targeting high-value estrogen receptor-positive breast cancer market.
Help build intelligence for Qilu Pharmaceutical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.